Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etifoxine for unipolar or bipolar depression
2024-512698-29-00Phase 2Completed
- Sponsor
- medbo
- Start
- Jul 2024
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of etifoxine in major depressive disorder (MDD) and bipolar disorder (BD) (2 arms), sponsored by medbo. Started Jul 2024; status: completed.
02
Drugs
etifoxine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on 2024-512698-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512698-29-00.